SOURCE: iSatori

iSatori

October 10, 2013 13:27 ET

iSatori Launches New Testosterone Support Formula Fenu Test™ to GNC Retail Stores Nationwide

GOLDEN, CO--(Marketwired - Oct 10, 2013) - iSatori, Inc. (OTCQB: IFIT) ("the Company") today announced the launch of its new natural testosterone support formula called Fenu Test with America's largest distributor of specialty dietary supplements, Europa Sports (www.europasports.com), and GNC retailers nationwide.

While the popular Biogenetic Laboratories division of iSatori is almost exclusively focused on weight-loss support supplements (including hCG Activator®, GCB Lean800™, and Garcinia Trim™, the #1 selling diet "new arrival" on GNC.com), iSatori has decided to strategically expand this line to help a wider range of customers seeking optimal health.

"Decreased energy and libido, increased body fat, as well as reduced feelings of well-being can often be attributed to lower levels of testosterone in men," explains Stephen Adele, Founder and Chief Executive Officer of iSatori, Inc. (www.isatori.com), "as scientifically determined, as they age, starting as young as 30 years old."

Fenu Test is a precise combination of natural botanical ingredients designed to promote increases in testosterone that may aid in improved sexual performance, improved strength, and, in combination with weight training and a healthy diet, dramatic improvements in body composition along with increased energy levels and feelings of well-being.

"Each of the individual ingredients in Fenu Test is safe and effective when used properly, and this is supported by several open-label clinical studies," noted Adele. "For instance, the primary formula was tested by the Ohio Research Group of Exercise and Sports Nutrition, led by Principle Investigator Dr. Ron Mendel, in a double-blind, placebo-controlled research study, where the results showed three impressive findings: increased free "bioavailable" testosterone; decreased estrodial ("the female hormone"); and equally important, all safety and blood markers were tested within healthy ranges."

iSatori has already begun to ship to retailers who placed pre-orders this month, and the product will be available in GNC stores nationwide and online at www.gnc.com in early November. As the exclusive distributor, Europa Sports, the nation's largest sports and health nutrition wholesale distributor, which supplies over 14,000 specialty and independent retailers, will also carry the new Fenu Test, along with the rest of the BioGenetic Laboratories products.

Retailers interested in carrying Fenu Test can contact Europa Sports at 1-800-447-4795 or visit http://www.EuropaSports.com.

About iSatori, Inc.

iSatori is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at http://www.isatori.com.

Forward-Looking Statements

Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. All forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update any such statement.

Contact Information

  • For additional information, please contact:

    Stephen Adele or Michael Wilemon
    (303) 215-9174
    Email Contact

    or

    W. Terrance Schreier
    Transition Partners, Limited
    303-938-6834
    Email Contact